GTO ID | GTC1012 |
Trial ID | ChiCTR2200064112 |
Disease | Advanced Tumor |
Therapy | CAR-T cell |
Treatment | CAR-T cells |
Phase | Phase1 |
Recruitment status | Recruiting |
Title | Clinical study on the safety and efficacy of cells in the treatment of advanced tumors |
Year | 2022 |
Country | China |
Company sponsor | Affiliated Hospital of Qingdao University |
Cohort 1 | |||||||
|